|
⚲
|
| Keyboard |
| Bertolino Arthur Peter
✚
|
|
|---|---|
| CIK # | 0001426344 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001426344] | |
| 4 | [0001426344] | |
| 5 | [0001426344] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cellceutix CORP | |
| Bertolino Arthur Peter | |
| Revance Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Cellceutix CORP IPIX
Class A Common Stock
|
2019-09-01 | Tax withheld | 421,611 | $0.13 | 54,809 |
|
Cellceutix CORP IPIX
Class A Common Stock
|
2018-10-12 | Tax withheld | 218,946 | $0.40 | 87,578 |
|
Cellceutix CORP IPIX
Class A Common Stock
|
2018-09-01 | Grant | 1,066,667 | $0.00 | |
|
Cellceutix CORP IPIX
Employee Stock Option (right to buy) · derivative
|
2018-09-01 | Grant | 617,839 | $0.00 | |
|
Cellceutix CORP IPIX
Class A Common Stock
|
2017-12-22 | Tax withheld | 238,048 | $0.70 | 166,634 |
|
Cellceutix CORP IPIX
Class A Common Stock
|
2017-09-01 | Grant | 1,066,667 | $0.00 | |
|
Cellceutix CORP IPIX
Employee Stock Option (right to buy) · derivative
|
2017-09-01 | Grant | 617,839 | $0.00 | |
|
Cellceutix CORP IPIX
Class A Common Stock
|
2017-06-27 | Tax withheld | 262,080 | $0.84 | 220,147 |
|
Cellceutix CORP CTIX
Stock Option · derivative
|
2016-06-30 | Grant | 617,839 | $0.00 | |
|
Cellceutix CORP CTIX
Common Stock
|
2016-06-30 | Grant | 1,066,667 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2015-11-17 | Sell | 15 | $39.55 | 593 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2015-11-17 | Sell | 5,425 | $39.11 | 212,172 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2015-11-17 | Sell | 36 | $39.55 | 1,424 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2015-11-17 | Sell | 2,277 | $39.11 | 89,053 |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2015-09-02 | Tax withheld | 3,699 | $30.48 | 112,746 |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2015-01-28 | Grant | 34,445 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2015-01-28 | Grant | 6,078 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Common Stock
|
2014-09-02 | Grant | 39,375 | $0.00 | |
|
Revance Therapeutics Inc RVNC
Stock Option (Right to buy) · derivative
|
2014-09-02 | Grant | 118,125 | $0.00 |